Mary’s Medicinals secures patent for transdermal marijuana gel

 In Medical Marijuana, National News

When Snoop Dogg coined the phrase “sticky icky icky,” he couldn’t have imagined that cannabis ingestion would evolve into weed patches and gels.

The topical technology took a step forward as Colorado-based Mary’s Medicinals received a Notice of Allowance from the U.S. Patent and Trademark Office for their cannabis-infused gel, used in the company’s Mary’s Medicinals Transdermal Pen.

In a nascent industry, patents such as these are quite rare, the company’s executives say.

“The PTO has only granted an extremely limited number of cannabis-related patents – almost exclusively to major international pharmaceutical corporations, research institutions and the federal government,” Mary’s Medicinals founder Nicole Smith said in press materials. “As a small startup company, securing this protection for our intellectual property and the recognition of the uniqueness of our offerings will bolster our continued leadership in this rapidly growing industry.”

Smith’s offerings are among the most diverse in the sector, focused on a wide variety of cannabinoids and delivery methods, including the now-patented gel. The transdermal patches, which are currently patent pending, are 2-inch squares and can be worn under clothing, aimed at consumers looking for a discreet method of uptake.


Recent Posts